Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted.docVIP

Available online /content/11/3/413 Letter Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted Darren M Roberts1,2 and Jason A Roberts3,4 1South Asian Clinical Toxicology Research Collaboration, Medical School, Australian National University, PO Box 5141, Kingston, Australian Capital Territory, Australia, 2604 2Department of Clinical Pharmacology and Toxicology, The Canberra Hospital, PO Box 5141, Kingston, Australian Capital Territory, Australia, 2604 3Burns, Trauma and Critical Ca